Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa

Details for Australian Patent Application No. 2009254257 (hide)

Owner Sanofi-Aventis

Inventors Broenstrup, Mark; Globisch, Anja; Schreuder, Herman; Kallus, Christopher; Wagner, Michael; Evers, Andreas

Agent Watermark

Pub. Number AU-A-2009254257

PCT Pub. Number WO2009/146802

Priority 08290520.9 06.06.08 EP

Filing date 22 May 2009

Wipo publication date 10 December 2009

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 273/01 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2009/146802 Priority application(s): WO2009/146802

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009254260-Method and system for purifying biogas for extracting methane

2009254255-Synergistic preservative blends